Bruck Kifle

Array ( [id] => 4021810 [patent_doc_number] => 05925567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Selective expansion of target cell populations' [patent_app_type] => 1 [patent_app_number] => 8/944755 [patent_app_country] => US [patent_app_date] => 1997-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 9951 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925567.pdf [firstpage_image] =>[orig_patent_app_number] => 944755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349017 [patent_doc_number] => 06291208 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Chimeric antibodies for delivery of antigens to selected cells of the immune system' [patent_app_type] => 1 [patent_app_number] => 8/943136 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 11377 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291208.pdf [firstpage_image] =>[orig_patent_app_number] => 943136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640041 [patent_doc_number] => 06395874 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Retinal pigment epithelial protein which suppresses neutrophil macrophage superoxide generation' [patent_app_type] => B1 [patent_app_number] => 08/940577 [patent_app_country] => US [patent_app_date] => 1997-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 33 [patent_no_of_words] => 22250 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395874.pdf [firstpage_image] =>[orig_patent_app_number] => 08940577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384789 [patent_doc_number] => 06294654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region' [patent_app_type] => 1 [patent_app_number] => 8/860904 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 8589 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294654.pdf [firstpage_image] =>[orig_patent_app_number] => 860904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050211 [patent_doc_number] => 05932443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Human antigens' [patent_app_type] => 1 [patent_app_number] => 8/937972 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21443 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932443.pdf [firstpage_image] =>[orig_patent_app_number] => 937972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297672 [patent_doc_number] => 06187311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Engineered acarid allergen and process for producing the same' [patent_app_type] => 1 [patent_app_number] => 8/930264 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5506 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187311.pdf [firstpage_image] =>[orig_patent_app_number] => 930264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998475 [patent_doc_number] => 06004565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties' [patent_app_type] => 1 [patent_app_number] => 8/933738 [patent_app_country] => US [patent_app_date] => 1997-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 26 [patent_no_of_words] => 12314 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004565.pdf [firstpage_image] =>[orig_patent_app_number] => 933738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093733 [patent_doc_number] => 06096551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Methods for producing antibody libraries using universal or randomized immunoglobulin light chains' [patent_app_type] => 1 [patent_app_number] => 8/931645 [patent_app_country] => US [patent_app_date] => 1997-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28480 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096551.pdf [firstpage_image] =>[orig_patent_app_number] => 931645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248129 [patent_doc_number] => 06207399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods' [patent_app_type] => 1 [patent_app_number] => 8/860808 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 43999 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207399.pdf [firstpage_image] =>[orig_patent_app_number] => 860808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234626 [patent_doc_number] => 06080404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Materials and methods for removal of substances from fluids' [patent_app_type] => 1 [patent_app_number] => 8/924689 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2919 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080404.pdf [firstpage_image] =>[orig_patent_app_number] => 924689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080233 [patent_doc_number] => 06054315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Method for making activated neutrophils recognizable to macrophages' [patent_app_type] => 1 [patent_app_number] => 8/924289 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10466 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054315.pdf [firstpage_image] =>[orig_patent_app_number] => 924289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977320 [patent_doc_number] => 05948628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Methods of screening for compounds which mimic galectin-1' [patent_app_type] => 1 [patent_app_number] => 8/929291 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10457 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948628.pdf [firstpage_image] =>[orig_patent_app_number] => 929291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3968947 [patent_doc_number] => 05886145 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/915972 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 8453 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886145.pdf [firstpage_image] =>[orig_patent_app_number] => 915972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936479 [patent_doc_number] => 05871930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'High affinity immunoglobulin E receptor-like protein' [patent_app_type] => 1 [patent_app_number] => 8/916902 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18973 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871930.pdf [firstpage_image] =>[orig_patent_app_number] => 916902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219183 [patent_doc_number] => 06111090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Mammalian cell surface antigens; related reagents' [patent_app_type] => 1 [patent_app_number] => 8/911423 [patent_app_country] => US [patent_app_date] => 1997-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21456 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111090.pdf [firstpage_image] =>[orig_patent_app_number] => 911423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346317 [patent_doc_number] => 06214572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Programmed cell death and ICH-3' [patent_app_type] => 1 [patent_app_number] => 8/908436 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 25228 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214572.pdf [firstpage_image] =>[orig_patent_app_number] => 908436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137576 [patent_doc_number] => 06030613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Receptor specific transepithelial transport of therapeutics' [patent_app_type] => 1 [patent_app_number] => 8/899856 [patent_app_country] => US [patent_app_date] => 1997-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13207 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030613.pdf [firstpage_image] =>[orig_patent_app_number] => 899856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930614 [patent_doc_number] => 05980898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Adjuvant for transcutaneous immunization' [patent_app_type] => 1 [patent_app_number] => 8/896085 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 1 [patent_no_of_words] => 17523 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980898.pdf [firstpage_image] =>[orig_patent_app_number] => 896085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930527 [patent_doc_number] => 05980893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis' [patent_app_type] => 1 [patent_app_number] => 8/895626 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7627 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980893.pdf [firstpage_image] =>[orig_patent_app_number] => 895626 [rel_patent_id] =>[rel_patent_doc_number] =>)